IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Valeant Pharmaceuticals

CUSIP: 91911XAQ7 | 1 institutional holders

Quarters

Q4 2014Q3 2014Q2 2014Q1 2014
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q4 2014

Advent Capital Management3,000,000
0.0% of portfolio›$3.1K
StyleTurnoverLocationFiled
Advent Capital Management
3,000,000$3.1K0.0%Deep ValueMediumNew York, NY2015-02-26